Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection have?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has 296 citations in the OpenAlex counts ScholarIQ stores.

When was Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection published?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has 2012 year in the ScholarIQ index.

What is the open-access status of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has hybrid oa status in the ScholarIQ index.

What is the DOI of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?

The DOI for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.

What is the PMID of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?

The PMID for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.

What is the OpenAlex record for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?

The OpenAlex for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.